Stay updated on Psilocybin for MDD: Novel Clinical Trial
Sign up to get notified when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.

Latest updates to the Psilocybin for MDD: Novel Clinical Trial page
- Check6 days agoChange DetectedThe page footer now displays Revision: v3.4.3, replacing Revision: v3.4.2.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedAdded Revision: v3.4.2; removed the lapse-in-government-funding notice and Revision: v3.4.1.SummaryDifference0.4%

- Check41 days agoChange DetectedNew: a government funding notice about potential delays and open status guidance appears on the page. New: the page revision tag updated to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

- Check48 days agoChange DetectedNew: Show glossary toggle; added QC-related metadata labels—including 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'—while removing 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing v3.3.3. There are no changes to the study details on the page.SummaryDifference0.0%

- Check84 days agoChange DetectedThe Locations section was expanded to include participating sites across multiple states under a consolidated listing, and older per-state subsections were removed with the revision updated to 3.3.3.SummaryDifference1%

Stay in the know with updates to Psilocybin for MDD: Novel Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Psilocybin for MDD: Novel Clinical Trial page.